The core activity of the department is the design and pre-clinical testing of tailor-made drug delivery systems for site-specific, time- and/or rate-controlled delivery of small molecular weight drugs, therapeutic proteins, nucleic acids (including DNA and siRNA), and antigens for therapy and prevention of life-threatening diseases such as cancer, inflammation and infectious diseases.


P.O.Box 80082 
3508 TB Utrecht 
The Netherlands 

tel +31 30 2537306 
fax +31 30 2517839 


Crisianne Rijcken
Thursday 26 January 2017
Cristal Therapeutics, a spin-off company from the dept. Pharmaceutics which develops nanomedicines announced that they have secured €12.8 million.
Bont and Sachs
Tuesday 21 April 2015
Second article regarding Seed Money Grants in Life Sciences.
Pieters en Wösten
Wednesday 18 March 2015
Resistance to antibiotics is a growing, urgent problem that requires new and better alternatives.